Status:

COMPLETED

QUantitative Flow Ratio Or Angiography for the assessMent of nOn-culprit Lesions

Lead Sponsor:

Johannes Gutenberg University Mainz

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The aim of this study is to study whether the use of complex 3-dimensional assessment of the severity of a stenosis improves angina and in general cardiovascular outcomes in patients who have residual...

Detailed Description

The study is a single-center, randomized superiority trial to compare two strategies for the assessment of the hemodynamic relevance of coronary lesions. The primary analysis will be on the per-proto...

Eligibility Criteria

Inclusion

  • Successfully treated acute coronary syndrome
  • At least one additional intermediate stenosis (\>30% and \<90%).
  • Patient ≥18 years old

Exclusion

  • Stenoses or patients a priori not amenable to treatment with PCI (at the discretion of two interventional cardiologists - e.g. patients with limited life expectancy, stenosis in very small vessels, very diffuse disease with complex/very calcified stenosis requiring surgery etc).
  • Persistent symptoms or evidence of ischemia requiring intervention of the non-culprit lesion.
  • Any contraindication to PCI according to guidelines
  • An ACS in the period following the index ACS and randomization
  • TIMI (Thrombolysis in Myocardial Infarction) flow grade \< 3 in the culprit vessel
  • Presence of thrombus in the non-culprit lesion
  • Participation in another randomized interventional study interfering with the present protocol
  • Patient unable to give informed consent
  • Women of child-bearing potential or lactating
  • Previous coronary artery bypass surgery CABG
  • Recent (within 30 days) unsuccessful PCI
  • Decompensated congestive heart failure (CHF) or hospitalization due to CHF during the last 3 months
  • Left ventricular ejection fraction \<30%
  • Severe chronic obstructive pulmonary disease (COPD)
  • Severe valvular heart disease
  • FFR (or RFR, iFR etc) assessment of non-culprit lesions at the time of the index procedure

Key Trial Info

Start Date :

October 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 17 2024

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04808310

Start Date

October 1 2020

End Date

April 17 2024

Last Update

October 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Center of Cardiology, Cardiology I, university hospital Mainz

Mainz, Rhineland-Palatinate, Germany, 55131